Have you ever wondered if someone like you participated in the clinical trials for a new drug? If you have, you are not alone. The FDA has made new information available through an online Drug Trials Snapshots database.
Holidays are often difficult for anyone who has experienced the death of a loved one. Rather than being times of family togetherness and sharing, holidays can bring feelings of sadness, loss and emptiness.
Digital Sympathectomy in Patients with Scleroderma
Periarterial sympathectomy is a treatment option for patients with systemic sclerosis suffering from digital vasculopathy. Despite potential benefits, this operation appears to be infrequently performed.
Disclaimer: The Scleroderma Foundation in no way
endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is
provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.
The Scleroderma Foundation is a qualified national nonprofit operating under 501(c)(3) status. The foundation’s federal tax identification number is 52-1375827. Our primary goal is to raise funds for our three-fold mission of support, education and research. The foundation has 20 active chapters and 160 support groups across the country.